The intrinsic lymphatic contractile activity is necessary for proper lymph transport.
Introduction
Insulin resistance is one of the major causes of metabolic syndrome (MetSyn) or related metabolic disorders that are associated with an enormous health burden worldwide 1 . MetSyn is now one of the most prevalent diseases globally and increases the risk for all causes of mortalities, including cardiovascular diseases 1, 2 . Clinical studies have established the link between obesity and lymphatic dysfunction, which is associated with increased susceptibility for developing lymphedema [3] [4] [5] [6] . Mice heterozygous for Prox1, a master lymphatic endothelial transcription factor, consistently develop adult onset obesity coupled with increased chyle accumulation in the thoracic cavity 7, 8 . In addition, these mice exhibited higher leptin and insulin levels contractile amplitude was diminished; whereas, T-type, 'transient, ' Ca 2+ channel inhibition reduced the stretch-induced phasic contractile frequency in the lymphatics 24 . Lymph flow was reduced by disrupting ER Ca 2+ in bovine lymphatic vessels 25 . Additionally, SERCA2
activity and expression are diminished in vascular smooth muscle 26, 27 and heart 28, 29 in different animal models of obesity/diabetes, highlighting a potential pathological role for SERCA2 dysfunction and disturbed intracellular Ca 2+ homeostasis in the development of metabolic abnormalities in insulin resistance and diabetes. However, the role of SERCA2 in lymphatic pumping activity and possible pathophysiological roles in MetSyn have not yet been examined.
Our previous data showed negative chronotropic effects at all transmural pressures that effectively reduced the intrinsic flow generating capacity of mesenteric lymphatic vessels in MetSyn rats 9, 10 . Additionally, insulin resistance increased MLC20 phosphorylation in LMCs 21 that is mediated by intracellular Ca 2+ 20 . Hence, we hypothesized that a decrease in SERCA expression and/or activity in lymphatic muscle influences Ca 2+ homeostasis in LMCs, and consequently, diminishes lymphatic contractile activity in MetSyn animals. To test this hypothesis, we assessed the expression of SERCA2 isoforms in lymphatic muscle and determined the role of SERCA2
in the regulation of lymphatic contraction in the normal and MetSyn conditions.
Results
MetSyn rats exhibit an altered body composition by decreasing skeletal muscle mass, but increasing body fat deposition and cardiac muscle mass.
We have previously reported hyperinsulinemia and hyperlipidemia in high-fructoseinduced MetSyn animals 9 . As we expected, blood glucose levels in the high-fructose diet fed rats were significantly increased (7.37 ± 0.39 vs.13.37 ± 0.55mM, control vs. MetSyn, p<0.05) compared with the control group rats in the normal-diet chow ( Table 1) . As we reported in our previous studies, we did not observe any significant increase in body mass over the 7-10 week diet period in MetSyn rats comparing to the control group. However, skeletal muscle mass was found to be decreased in the MetSyn group when compared to the controls, which is consistent with the common pathological phenotype in metabolic disorders 30 . Soleus and TA muscles from MetSyn rats showed a significant decrease in muscle mass (p<0.05) and in the fiber type distribution that is skewed to the smaller muscle fiber (Figures 1 A-D) . In contrast, accumulation of body fat in both visceral and inguinal subcutaneous fat pad was significantly higher in MetSyn rats (Table 1) .
Additionally, heart weight was significantly increased in MetSyn animals and exhibited enlarged cardiac myocytes comparing with the myocytes from control rats (Table 1 and Figure 1 ). Figure 2 ). 2μM thapsigargin was found to severely impair the lymphatic contractions with decreased frequency and amplitude, and thus fractional pump flow and ejection fraction (Figure 2 ). Therefore, we employed 1.5μM of thapsigargin to examine the role of SERCA activity in the regulation of lymphatic vessel contractility of MetSyn animals.
SERCA inhibition abolishes intrinsic lymphatic pumping activity

SERCA activity is diminished in MetSyn lymphatic vessels
In control lymphatic vessels, as discussed above, the phasic contractile frequency was decreased at each employed pressure, in the presence of thapsigargin (10.27 ± 0.59 vs.
7.96 ± 0.9, 11.12 ± 0.69 vs. 9.14 ± 1.27, and 12.19 ± 0.73 vs. 9.58 ± 1.06 contractions per min, at 1, 2, and 3 H2O pressure respectively), but was not statistically significant (Figures 3A and C, Table 2 ). In MetSyn animals, contractile frequency was significantly decreased compared to control animals (6.59 ± 0. . However, thapsigargin did not further decrease the contractile frequency of lymphatic vessels from MetSyn animals. In addition, the reduction in contractile frequency due to thapsigargin in control animals was found to be similar to the contractile frequency in MetSyn animals ( Figure 3C ). Additionally, thapsigargin significantly reduced the ejection fraction in both control and MetSyn animals at transmural pressures, P=1, 3 and 5 cmH2O, while there was no significant difference between the control and MetSyn groups ( Figure 3D ). The fractional pump flow and lymph flow were also reduced significantly by thapsigargin in control lymphatic vessels in all transmural pressures . A summary of all the lymphatic contractile parameters is given in Table 2 .
Decreased SERCA2a expression in MetSyn lymphatic vessel
To assess the expression of SERCA, we performed immunofluorescence analyses on isolated mesenteric lymphatic vessels from control and MetSyn rats using striated muscle-specific SERCA2a or striated and smooth muscle isoform, SERCA2b specific antibody co-stained with α-smooth muscle actin (α-SMA) antibody. Both SERCA2a and Figures 4A and B) ; however, there was no significant differences in the SERCA2b expression among the control and MetSyn groups. We further examined the relative levels of MLC20 phosphorylation in the control and MetSyn lymphatic vessels.
MetSyn lymphatic vessels displayed significantly higher levels of phosphorylated MLC20
(p<0.008, Figure 4E -F).
Insulin resistance impaired SERCA2 activity in LMCs.
To address whether insulin resistance conditions in LMCs impair SERCA activity and expression, and calcium regulation, LMCs were cultured in hyperglycemia and hyperinsulinemia conditions for 48 h as described in our previous study 21 . . LMCs were grown in the media containing different free calcium concentration solution (calcium free to pCa3.5). MLC20 phosphorylation was found to be increased in LMCs grown under increasing extracellular Ca 2+ concentrations and showed significant increase at pCa 6.5 or at higher pCa (p<0.05, Figure 5H ).
Activation of SERCA pump partially improves lymphatic contractile activity in
MetSyn animals.
CDN1163 is a small molecule that activates SERCA2 by directly binding to the SERCA2 structure and increases SERCA2 Vmax activity [34] [35] [36] .
In this study, we tested whether exogenously adding CDN1163 in the isolated lymphatic vessel preparations of MetSyn rats would improve its pumping activity. We selected different doses of CDN1163 (1, 5, and 10μM) based on previous studies. We initially determined the effects of CDN1163 on lymphatic contractile parameters of the control vessels. While lymphatic contractile frequency was not affected in the presence of 1μM CDN 1163, 5μM CDN1163
significantly increased contractile frequency of lymphatic vessels at transmural pressures, 3cmH2O (17.74 ± 2.7 contractions/min, p<0.022) and 5cmH2O (18.16 ± 1.9
contractions/min, p<0.016, Figure 6B ). Lymphatic contractile frequency was increased at all different transmural pressures in the presence of 10μm CDN1163 (p<0.001, Figure   6B ). Though CDN1163 did not alter significantly the contractile amplitude, stroke volume, lymph flow, tone, and ejection fraction, there was a trend that lymphatic contractile amplitude and ejection fraction were decreased in a dose dependent manner (data not shown). Therefore, even if CDN1163 significantly increased contractile frequency of control lymphatic vessels, lymphatic fractional pump flow did not change at all different transmural pressures in the presence of 5μm CDN1163 ( Figure 6C ). Hence, we used 5μm CDN1163 that showed positive chronotropic effect without negative inotropic effect Table 2 .
Discussion
The data presented in this study provide the first evidence that the striated musclespecific, SERCA2a pump that is present in lymphatic muscle modulates the lymphatic pumping activity by regulating phasic contractile amplitude and frequency, but not the lymphatic tone. Additionally, diminished lymphatic contractile activity in the vessels from the MetSyn animal is associated with the decreased SERCA2a expression and impaired , and altered body composition signifies the important pathological aspects of our MetSyn model. In addition, the muscle loss in obesity or metabolic disease could result from chronic inflammation [42] [43] [44] . . Hence, we speculate that muscle atrophy in fructose diet-induced MetSyn rats could be due to systemic inflammatory effects. Cardiac hypertrophic remodeling is one of the prevailing pathological features of metabolic disorders due to chronic systemic inflammation [46] [47] [48] .
Our data showed that hearts from fructose-induced MetSyn rats displayed increased heart weight and enlarged cardiomyocyte cross-sectional area ( , lymphatic contractility indexes, frequency of contraction and lymphatic fractional pump flow, were significantly reduced in MetSyn rats when compared to control group ( Figure 3C and E). Our data showing that the SERCA inhibitor, thapsigargin significantly reduces the contractility indexes of lymphatic vessels from control group, but not the vessels from MetSyn animals ( Figures 3C, E and F) ,
suggesting that SERCA activity is already diminished in MetSyn lymphatic vessels.
Ejection fraction was significantly lowered in the presence of thapsigargin compared to each cohort groups ( Figure 3D ) and this might be due to the similar level of contractile amplitude between control and MetSyn.
Three distinct genes encoding SERCA 1, 2, and 3 produce more than 10 isoforms that are expressed in various muscles and non-muscle cells . Here, we report that lymphatic muscle cells express both SERCA2a and SERCA2b isoforms ( Figures 4A, 5D , F and G), further supporting our previous finding that lymphatic muscle presents a unique combination of muscle cell types that express both cardiac and smooth muscle contractile and regulatory proteins [34] [35] [36] . Our data show that SERCA activation significantly improves the lymphatic contractile frequency in In summary, the current study demonstrates that SERCA2 activation plays an important role in modulating lymphatic pump function and lymph flow by regulating chronotropic and inotropic effects. The rat mesenteric lymphatic muscle expresses both SERCA2a and SERCA2b isoforms. MetSyn conditions decreased the levels of SERCA2a expression and impaired Ca 2+ regulation in LMCs that are coupled with increased MLC20
phosphorylation. The impaired lymphatic pumping activity in MetSyn is due to diminished SERCA activity and activating SERCA partially improves lymph flow in MetSyn.
Therefore, it is possible that SERCA2 agonist could be used as a therapeutic strategy in enhancing lymphatic function in MetSyn or other metabolic diseases.
METERIALS AND METHODS
Materials
Phospho MLC20 (Ser19), total MLC20, β-actin antibodies were purchased from Cell 
Animal Handling
Fifty-two male Sprague-Dawley rat weighing 150-180g were ordered from Charles River for induction of the MetSyn. Twenty rats were given a high fructose diet (60% fructose, 
Determination of metabolic parameters
High fructose diet generates a rat model of MetSyn as characterized by high insulin, glucose, triglycerides, and glucose levels along with impaired insulin sensitivity 37,58-60 .
We also confirmed the development of MetSyn conditions by measuring plasma insulin, triglyceride, inflammatory cytokines in mesentery and cecum histopathological changes 9, 10 . To confirm the pathology of high fructose diet-induced MetSyn we measured blood glucose using a glucometer and test strips before surgery. Heart was isolated, weighted, and then the left ventricle was dissected for measuring cardiac hypertrophy. Quadriceps, tibial anterior (TA), and soleus muscles were isolated and weighed for assessing sarcopenic obesity, which is systemic pathology due to metabolic disorders. Inguinal subcutaneous adipose tissue (SWAT) and epididymal white adipose tissue (EWAT) were dissected to determine the percent of subcutaneous and visceral fat.
Lymphatic vessel isolation and functional analysis
Rat mesenteric collecting lymphatic vessel isolation and cannulation were performed to test isobaric lymphatic pumping activity as described in our previous studies 9, 10, 18 . Rats were anesthetized with Innovar-Vet (0.3 ml/Kg), which is a combination of a droperidol- .
LMC culture and treatments
Primary rat mesenteric LMCs were obtained from mesenteric tissue explants of male Sprague-Dawley rats, as we have described in previous publications 12, 21 . Cells from passages 3-6 were used in all experiments. LMCs were cultured in DMEM, containing 10% FBS, and 1% triple antibiotics and maintained at 37 ºC in 10% CO2 incubator. LMCs were plated in 24-well culture plates and then grown to ~70-80% confluence. The cells were serum starved for 24 h and treated with 5mM glucose (control) or high glucose (HG; 25mM), with or without insulin (100nM) for 48h as we reported in a previous study 21 . To test the effects of free intracellular Ca
2+
, different concentrations of pCa solutions (between pCa7.5 to 3.5) were prepared based on Ca free DMEM using a software, MaxChelator as described 63, 64 . After serum starvation, LMCs were treated with Ca 2+ free DMEM and different concentrations of free calcium (pCa 7.5-3.5) for 30 minutes. Proteins were isolated as described in our previous studies 21, 45 .
Intracellular Ca 2+ measurement in LMCs
Intracellular Ca 2+ levels were measured using fura-2AM in phenol-free DMEM media as described [65] [66] [67] . LMCs were plated in glass bottom chamber and treated when LMCs 
Immunofluorescence analyses
To determine the relative levels of SERCA2a, SERCA2b, and MLC20 phosphorylation, rat mesenteric lymphatic vessels were prepared for 
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# p<0.008 vs. Control. Data are presented as mean ± SE. 
